Clinical Trials - Gorlin Syndrome Alliance

The information on this page has been obtained from clinicaltrials.gov .

The trials listed here are being conducted by pharmaceutical companies and physicians who are partnering with or have contacted the Gorlin Syndrome Alliance.

For a complete listing, please go to clinicaltrials.gov.

RECRUITING

“Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

FULLY ENROLLED

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma – Full Text View – ClinicalTrials.gov

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome – Full Text View – ClinicalTrials.gov